Intrinsic Value

Is REG1V undervalued or overvalued?

See the intrinsic value estimate for Revenio Group Oyj and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

REG1V Intrinsic Value
LOCKED
Unlock
Today vs. history

REG1V looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with REG1V’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor REG1V
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €11.1
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to REG1V

Fundamental Analysis

What Revenio Group Oyj Does

Health Care

Revenio Group Oyj is a medical technology company best known for devices and software used to screen and monitor eye disease, especially glaucoma and other conditions that can damage vision. It also makes tools for bone health assessment. The company sells mainly to eye clinics, hospitals, screening programs, and other healthcare providers that need reliable diagnostic equipment.

Headquarters
Finland FI
Employees
246
IPO date
Jan 1, 2003
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Revenio Group Oyj

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one REG1V stock?

The intrinsic value for Revenio Group Oyj (REG1V) under the Base Case is hidden EUR.

Is REG1V stock undervalued or overvalued?

Compared with the current market price of 11.1 EUR, the stock appears hidden.

Back to Top